Reblozyl (Luspatercept)

**Product type:** Human Prescription Drug

**Active ingredient:** LUSPATERCEPT

**Strength:** 25 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Subcutaneous

**Labeler:** Celgene Corporation

**Marketing category:** BLA (BLA761136)

**Pharmacologic class:** Erythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE]